$60.60 -0.54 (%) Bristol-Myers Squibb Co - NYSE

Jan. 30, 2015 | 11:51 AM

Partner Headlines

  1. Strong Dollar Weakens Views

    IBD | Jan. 27, 2015 | 18:48PM EST
  2. Drugmakers Warn On Dollar

    IBD | Jan. 27, 2015 | 18:47PM EST
  3. Strong Dollar Pins U.S. Corporate Earnings Outlook

    IBD | Jan. 27, 2015 | 18:29PM EST
  4. Drug Firms Report Good Q4, But Outlook Cloudy

    IBD | Jan. 27, 2015 | 18:10PM EST
  5. Strong Dollar Means Flabby Outlook For Some Overseas

    IBD | Jan. 27, 2015 | 13:45PM EST
  6. Bristol, Pfizer, Novartis Forecasts Face FX Pressures

    IBD | Jan. 27, 2015 | 11:57AM EST
  7. Tuesday Morning Movers: Microsoft, Procter & Gamble Tumble Following Earnings

    Benzinga | Jan. 27, 2015 | 09:19AM EST
  8. UPDATE: Bristol-Meyers Squibb Posts Upbeat Q4 Results, Issues Downbeat Forecast

    Benzinga | Jan. 27, 2015 | 08:39AM EST
  9. Earnings Scheduled For January 27, 2015

    Benzinga | Jan. 27, 2015 | 04:34AM EST
  10. Pharmaceuticals Sector To See High Voltage Action in 2015

    GuruFocus | Jan. 23, 2015 | 16:13PM EST
  11. 3 High-Flying Health Care Stock IPOs To Watch In 2015

    IBD | Jan. 21, 2015 | 17:09PM EST
  12. BRISTOL-MYERS SQUIBB

    IBD | Jan. 20, 2015 | 18:44PM EST
  13. Bristol-Myers Squibb Names Caforio CEO, Andreotti To Become Chairman

    Benzinga | Jan. 20, 2015 | 17:09PM EST
  14. Feeling Good With This Med Company

    GuruFocus | Jan. 20, 2015 | 15:12PM EST
  15. 10 Biotech Stories You Might've Missed This Week

    Benzinga | Jan. 15, 2015 | 13:18PM EST
  16. Eli Lilly Has 'Turned The Corner,' Upgraded

    IBD | Jan. 15, 2015 | 11:02AM EST
  17. Celgene Outlook Is Upbeat

    IBD | Jan. 12, 2015 | 18:58PM EST
  18. Celgene, Bristol-Myers Cancer Drug News Lifts Stocks

    IBD | Jan. 12, 2015 | 18:48PM EST
  19. Bristol-Myers Hits 14-Year High On Cancer Drug Trial

    IBD | Jan. 12, 2015 | 14:25PM EST
  20. Biotechs Presenting At The J.P. Morgan Healthcare Conference: Day 2

    Benzinga | Jan. 12, 2015 | 11:03AM EST
  21. Morning Market Gainers

    Benzinga | Jan. 12, 2015 | 09:42AM EST
  22. Credit Suisse: Keep An Eye On These 6 Healthcare Stocks In 2015

    Benzinga | Jan. 11, 2015 | 12:59PM EST
  23. What Investors Should Expect From Portola Pharmaceutical's Upcoming Data Readouts

    Benzinga | Jan. 9, 2015 | 12:43PM EST
  24. Jim Cramer Advises His Viewers On Wynn Resorts And Second Sight Medical Products

    Benzinga | Jan. 6, 2015 | 07:53AM EST
  25. Bristol-Myers Squibb and California Institute for Biomedical Research Sign Worldwide Research Collaboration and License Agreement Focused on New Treatment Approaches for Fibrotic Diseases

    Benzinga | Jan. 5, 2015 | 08:01AM EST
  26. 5 Biotech Stocks With Big News Due In January

    IBD | Dec. 31, 2014 | 13:15PM EST
  27. FDA's OKs may prescribe hits

    IBD | Dec. 26, 2014 | 18:49PM EST
  28. 4 Potential Blockbuster Drugs The FDA Just Approved

    IBD | Dec. 26, 2014 | 12:35PM EST
  29. Meet 5 Top Biotech Stocks Holding Up In Shaky Market

    IBD | Dec. 13, 2014 | 08:02AM EST
  30. Celgene drug could gain share

    IBD | Dec. 11, 2014 | 19:00PM EST
  31. Celgene's Abraxane Succeeds In Early Breast Cancer

    IBD | Dec. 11, 2014 | 11:27AM EST
  32. Merck's Keytruda Might Treat Virulent Breast Cancer

    IBD | Dec. 10, 2014 | 11:04AM EST
  33. US Stock Futures Edge Lower Ahead Of Federal Budget

    Benzinga | Dec. 10, 2014 | 07:01AM EST
  34. T Rowe Price's Top Stakes for the Third Quarter

    GuruFocus | Dec. 9, 2014 | 10:16AM EST
  35. I think Zimmer Will Outperform S&P 500 Performance

    GuruFocus | Dec. 4, 2014 | 10:06AM EST
  36. Avanir Stock Jumps On $3.5 Billion Otsuka Buyout

    IBD | Dec. 2, 2014 | 11:22AM EST
  37. A Buy Recommendation From Absolute Valuation Model to Bristol-Myers Squibb

    GuruFocus | Nov. 24, 2014 | 13:05PM EST
  38. Screening Pharma Stocks Amid Turnaround

    YCharts | Nov. 19, 2014 | 09:37AM EST
  39. Incyte Building Blockbuster Drug One Disease At A Time

    IBD | Nov. 17, 2014 | 15:58PM EST
  40. Blackhill Bets Almost Half of Portfolio on Williams-Sonoma

    GuruFocus | Nov. 10, 2014 | 16:00PM EST
  41. Merck Down On Hepatitis C Data; Gilead Rises

    IBD | Nov. 10, 2014 | 11:14AM EST
  42. A Look at the Top Five Medical Stocks Held in the Vanguard Portfolio

    GuruFocus | Nov. 9, 2014 | 18:16PM EST
  43. Dan Nathan Sees Unusual Options Activity In Bristol-Myers Squibb Co

    Benzinga | Oct. 31, 2014 | 07:49AM EST
  44. Lung cancer drug promising

    IBD | Oct. 30, 2014 | 19:14PM EST
  45. Bristol-Myers Lung-Cancer Drug Boosts Survival

    IBD | Oct. 30, 2014 | 11:31AM EST
  46. #PreMarket Primer: Monday, October 27: ECB Stress Tests In-Line With Expectations

    Benzinga | Oct. 27, 2014 | 08:19AM EST
  47. Eliquis revives Bristol-Myers

    IBD | Oct. 24, 2014 | 18:27PM EST
  48. Bristol-Myers Beats Q3 Views As Eliquis Revives

    IBD | Oct. 24, 2014 | 13:23PM EST
  49. Stocks Flat In Mixed Volume; Amazon.com Weighs On Techs

    IBD | Oct. 24, 2014 | 10:52AM EST
  50. UPDATE: Bristol-Myers Squibb Q3 Earnings Top Estimates

    Benzinga | Oct. 24, 2014 | 08:59AM EST
Trading Center